Physician profile
Stanley D Rich
NPI 1437129111
$1,069.33
in general payments reported to CMS, 2019-2025
13 companies · $23.56 in 2025
The $23.56 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $211 · 2021: $158 · 2022: $241 · 2023: $32.03 · 2024: $4.36 · 2025: $23.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $293.76 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $212.03 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $211.51 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $132.89 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.44 | 2020-2022 | |
| Canon Medical Systems USA, INC. | $27.38 | 2019 | |
| Abbott Laboratories | $23.56 | 2025 | Xience Skypoint |
| Pfizer INC. | $23.43 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $17.69 | 2020 | |
| Gilead Sciences, INC. | $14.83 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.11 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $11.80 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.90 | 2023-2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Rich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.